# CALC (CalciMedica, Inc.) - SEC EDGAR Financial Statements

> CalciMedica, Inc. reported $14.29M in total assets and a net loss of $15.11M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CALC
- Markdown: https://convexityos.com/fundamentals/CALC.md
- SEC CIK: 0001534133
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001534133&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$18.76M | Operating profit |
| Net Income | FY 2025 | -$15.11M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.19 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$18.20M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $13.77M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $15.23M | $14.48M | $15.86M | $8.35M | $18.90M | $20.96M | $30.58M |
| Total Operating Expenses | $23.12M | $24.20M | $38.08M | $14.19M | $35.95M | $29.83M | $37.50M |
| **Operating Income** | -$23.12M | -$24.20M | -$38.08M | -$14.19M | -$35.95M | -$29.83M | -$37.50M |
| **EBITDA** | -$23.07M | -$24.15M | -$38.02M | -$14.14M | -$35.43M | -$29.44M | -$37.20M |
| Interest Income | -- | -- | -- | $575K | $126K | $143K | $393K |
| Interest Expense | $1.42M | $0 | -- | -- | -- | -- | -- |
| Income Before Tax | -$29.56M | -$13.70M | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $1.0K | $1.0K | -- | -- | -- |
| **Net Income** | -$29.56M | -$13.70M | -$34.36M | -$7.82M | -$35.82M | -$27.53M | -$37.04M |
| Basic EPS | -$10.20 | -$6.32 | -$39.67 | -$575.66 | -$8.75 | -$27.19 | -$173.02 |
| **Diluted EPS** | -$10.20 | -$6.32 | -$39.67 | -$575.66 | -$8.75 | -$27.19 | -$173.02 |
| Basic Shares Outstanding | 2.9M | 2.2M | 866.3K | 15.9K | 4.1M | 1.3M | 254.9K |
| Diluted Shares Outstanding | 2.9M | 2.2M | 866.3K | 15.9K | 4.1M | 1.3M | 254.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.32M | $2.10M | $3.48M | $3.11M | $3.85M | $4.05M | $4.22M | $3.83M |
| Total Operating Expenses | $4.75M | $4.01M | $5.61M | $4.38M | $5.62M | $6.62M | $6.50M | $6.17M |
| **Operating Income** | -$4.75M | -$4.01M | -$5.61M | -$4.38M | -$5.62M | -$6.62M | -$6.50M | -$6.17M |
| **EBITDA** | -$4.74M | -$4.00M | -$5.60M | -$4.38M | -$5.61M | -$6.61M | -$6.48M | -$6.16M |
| Interest Expense | $357K | $325K | $319K | $325K | $326K | $324K | $447K | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$1.67M | -$7.65M | $4.98M | -$10.76M | -$7.80M | -$5.96M | -$5.04M | -$4.26M |
| Basic EPS | -$0.24 | -$2.33 | $1.61 | -- | -$2.59 | -$2.07 | -$1.86 | -- |
| **Diluted EPS** | -$0.24 | -$2.33 | $1.55 | -- | -$2.59 | -$2.07 | -$1.86 | -- |
| Basic Shares Outstanding | 6.9M | 3.3M | 3.1M | -- | 3.0M | 2.9M | 2.7M | -- |
| Diluted Shares Outstanding | 6.9M | 3.3M | 3.2M | -- | 3.0M | 2.9M | 2.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.52M | $7.93M | $5.53M | $1.33M | $13.36M | $33.42M | $15.87M |
| Short-Term Investments | $1.50M | $10.73M | $5.71M | $0 | $50.31M | $61.62M | $20.09M |
| **Cash & Short-Term Investments** | $13.00M | $18.70M | $11.20M | $1.33M | $63.67M | $95.03M | $35.96M |
| Other Current Assets | -- | -- | -- | -- | $1.35M | $1.46M | -- |
| **Total Current Assets** | $13.53M | $19.66M | $11.61M | $1.73M | $67.08M | $99.24M | $36.27M |
| Property, Plant & Equipment, Net | $50K | $119K | $167K | $147K | $1.98M | $1.95M | $1.98M |
| **Total Non-Current Assets** | $61K | $129K | $580K | $1.62M | $2.01M | $2.55M | $4.39M |
| **Total Assets** | $13.59M | $19.79M | $12.19M | $3.35M | $69.09M | $101.8M | $40.66M |
| Accounts Payable | $1.16M | $2.00M | $1.42M | $2.87M | $527K | $2.51M | $4.64M |
| Other Current Liabilities | -- | -- | $0 | $199K | $3.23M | $3.13M | $3.12M |
| **Total Current Liabilities** | $3.78M | $3.68M | $4.03M | $4.78M | $4.06M | $7.00M | $12.25M |
| **Total Non-Current Liabilities** | $16.45M | $1.70M | $0 | $7.80M | $8.0K | $11K | $0 |
| **Total Liabilities** | $20.23M | $5.38M | $4.03M | $12.58M | $4.07M | $7.01M | $12.25M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $203K | -- | -- | -- |
| Common Stock | $0 | $4.0K | $1.0K | $1.0K | $2.0K | $2.0K | -- |
| Retained Earnings | -$189.3M | -$159.8M | -$146.1M | -$111.7M | -$169.2M | -$133.4M | -$105.8M |
| Accumulated Other Comp. Income | $0 | $4.0K | $2.0K | -$37K | -$16K | -$4.0K | $3.0K |
| **Total Stockholders' Equity** | -$6.64M | $14.41M | $8.16M | -$71.30M | -$63.99M | $94.79M | -$103.0M |
| Total Equity | -$6.64M | $14.41M | $8.16M | -$71.30M | -$63.99M | $94.79M | -$103.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.57M | $18.62M | $8.16M | $11.52M | $5.47M | $5.92M | $12.56M | $7.93M |
| Short-Term Investments | $9.19M | $0 | $0 | $1.50M | $8.61M | $12.04M | $12.07M | $10.73M |
| **Cash & Short-Term Investments** | $13.80M | $18.60M | $8.20M | $13.00M | $14.10M | $18.00M | $24.60M | $18.70M |
| **Total Current Assets** | $14.22M | $19.46M | $8.55M | $13.53M | $14.85M | $18.96M | $25.22M | $19.66M |
| Property, Plant & Equipment, Net | $72K | $36K | $43K | $50K | $49K | $105K | $118K | $119K |
| **Total Non-Current Assets** | $76K | $40K | $54K | $61K | $60K | $116K | $129K | $129K |
| **Total Assets** | $14.29M | $19.50M | $8.61M | $13.59M | $14.91M | $19.08M | $25.35M | $19.79M |
| Accounts Payable | $1.02M | $2.07M | $1.68M | $1.16M | $1.13M | $1.91M | $2.02M | $2.00M |
| **Total Current Liabilities** | $2.87M | $3.49M | $5.31M | $3.78M | $3.68M | $3.48M | $4.46M | $3.68M |
| **Total Non-Current Liabilities** | $7.20M | $10.50M | $4.40M | $16.45M | $11.50M | $9.50M | $10.00M | $1.70M |
| **Total Liabilities** | $10.07M | $13.99M | $9.71M | $20.23M | $15.18M | $12.98M | $14.46M | $5.38M |
| Common Stock | $1.0K | $6.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K |
| Retained Earnings | -$193.7M | -$192.0M | -$184.3M | -$189.3M | -$178.6M | -$170.8M | -$164.8M | -$159.8M |
| Accumulated Other Comp. Income | -$7.0K | -$1.0K | -- | $0 | $1.0K | -$4.0K | -$1.0K | $4.0K |
| **Total Stockholders' Equity** | $4.23M | $5.51M | -$1.10M | -$6.64M | -$268K | $6.10M | $10.89M | $14.41M |
| Total Equity | $4.23M | $5.51M | -$1.10M | -$6.64M | -$268K | $6.10M | $10.89M | $14.41M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$29.56M | -$13.70M | -$34.36M | -$7.82M | -$35.82M | -$27.53M | -$37.04M |
| Depreciation & Amortization | $46K | $58K | $58K | $52K | $519K | $395K | $303K |
| Stock-Based Compensation | $2.97M | $2.31M | $12.04M | $1.81M | $5.38M | $1.79M | $738K |
| Change in Payables | -$840K | $601K | -$1.43M | $933K | -$2.05M | -$1.46M | $1.40M |
| **Operating Cash Flow** | -$21.18M | -$21.15M | -$25.73M | -$11.76M | -$31.50M | -$32.06M | -$31.21M |
| Capital Expenditure | -$28K | -$8.0K | -$78K | -$4.0K | -$488K | -$1.02M | -$605K |
| **Free Cash Flow** | -$21.21M | -$21.15M | -$25.81M | -$11.76M | -$31.99M | -$33.09M | -$31.82M |
| Purchases of Investments | -$15.92M | -$29.00M | -$6.12M | -$35.57M | -$94.57M | -$61.64M | -- |
| Sales & Maturities of Investments | $25.50M | $24.59M | $15.08M | $64.35M | $105.8M | $20.10M | -- |
| **Investing Cash Flow** | $9.55M | -$4.42M | $8.88M | -$4.0K | $10.75M | -$42.56M | -$20.62M |
| Common Stock Issued | $8.0K | $27.91M | $10.34M | -- | -- | $96.25M | -- |
| **Financing Cash Flow** | $15.21M | $27.97M | $20.90M | $8.48M | $695K | $92.17M | $54.87M |
| **Net Change in Cash** | $3.58M | $2.40M | $4.05M | -$3.29M | -$20.05M | $17.55M | $3.04M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.67M | -$7.65M | $4.98M | -$10.76M | -$7.80M | -$5.96M | -$5.04M | -$4.26M |
| Depreciation & Amortization | $7.0K | $7.0K | $7.0K | $5.0K | $12K | $14K | $15K | $14K |
| Stock-Based Compensation | $496K | $540K | $561K | $622K | $625K | $1.18M | $549K | $632K |
| Change in Payables | -$328K | -$627K | $514K | $44K | -$796K | -$1.0K | -$87K | $484K |
| **Operating Cash Flow** | -$3.86M | -$4.62M | -$4.86M | -$4.85M | -$4.78M | -$6.67M | -$4.88M | -$4.97M |
| Capital Expenditure | $0 | $0 | $0 | -$6.0K | -$8.0K | -$5.0K | -$9.0K | -$2.0K |
| **Free Cash Flow** | -$3.86M | -$4.62M | -$4.86M | -$4.86M | -$4.79M | -$6.67M | -$4.89M | -$4.97M |
| Purchases of Investments | -$9.14M | $0 | $0 | -$496K | -$1.48M | -$7.31M | -$6.63M | -$10.16M |
| Sales & Maturities of Investments | $0 | $0 | $1.50M | $7.65M | $5.00M | $7.45M | $5.40M | $5.00M |
| **Investing Cash Flow** | -$9.14M | $42K | $1.50M | $7.15M | $3.51M | $134K | -$1.24M | -$5.17M |
| Common Stock Issued | -$830K | $12.00M | $0 | $0 | $0 | $0 | $8.0K | $8.92M |
| **Financing Cash Flow** | -$1.04M | $15.03M | $0 | $3.75M | $818K | -$102K | $10.74M | $8.92M |
| **Net Change in Cash** | -$14.04M | $10.45M | -$3.36M | $6.05M | -$448K | -$6.64M | $4.62M | -$1.22M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -95.1% | -421.2% | -- | -- | -29.0% | -- |
| Return on Assets (ROA) | -217.5% | -69.2% | -282.0% | -233.6% | -51.8% | -27.0% | -91.1% |
| Current Ratio | 3.58x | 5.34x | 2.88x | 0.36x | 16.53x | 14.18x | 2.96x |
| Quick Ratio | 3.44x | 5.08x | 2.78x | 0.28x | 15.69x | 13.58x | 2.93x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -357.5% | -385.3% | -- | -- | -- | -342.0% | -173.3% | -95.1% |
| Return on Assets (ROA) | -105.7% | -108.9% | -227.0% | -217.5% | -154.6% | -109.4% | -74.5% | -69.2% |
| Current Ratio | 4.96x | 5.58x | 1.61x | 3.58x | 4.04x | 5.45x | 5.66x | 5.34x |
| Quick Ratio | 4.81x | 5.33x | 1.54x | 3.44x | 3.83x | 5.18x | 5.52x | 5.08x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -3978.5% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -3699.0% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
